← Browse by Condition
Medical Condition

pearson syndrome

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06017869 Phase 2
Recruiting

Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)

Enrollment
6 pts
Location
Israel
Sponsor
Minovia Therapeutics Ltd.
View Trial →